AU4825699A - Identification and use of differentially expressed genes and polynucleotide sequences - Google Patents

Identification and use of differentially expressed genes and polynucleotide sequences

Info

Publication number
AU4825699A
AU4825699A AU48256/99A AU4825699A AU4825699A AU 4825699 A AU4825699 A AU 4825699A AU 48256/99 A AU48256/99 A AU 48256/99A AU 4825699 A AU4825699 A AU 4825699A AU 4825699 A AU4825699 A AU 4825699A
Authority
AU
Australia
Prior art keywords
identification
polynucleotide sequences
differentially expressed
expressed genes
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48256/99A
Inventor
Bruce L. Roberts
Srinivas Shankara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Priority claimed from PCT/US1999/013820 external-priority patent/WO1999066303A2/en
Publication of AU4825699A publication Critical patent/AU4825699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU48256/99A 1998-06-19 1999-06-17 Identification and use of differentially expressed genes and polynucleotide sequences Abandoned AU4825699A (en)

Applications Claiming Priority (59)

Application Number Priority Date Filing Date Title
US9003698P 1998-06-19 1998-06-19
US8987898P 1998-06-19 1998-06-19
US8999798P 1998-06-19 1998-06-19
US8985398P 1998-06-19 1998-06-19
US9003998P 1998-06-19 1998-06-19
US9004098P 1998-06-19 1998-06-19
US9000098P 1998-06-19 1998-06-19
US8999298P 1998-06-19 1998-06-19
US9008098P 1998-06-19 1998-06-19
US8999198P 1998-06-19 1998-06-19
US9004798P 1998-06-19 1998-06-19
US9003598P 1998-06-19 1998-06-19
US9007998P 1998-06-19 1998-06-19
US9007298P 1998-06-19 1998-06-19
US8999998P 1998-06-19 1998-06-19
US9004498P 1998-06-19 1998-06-19
US9007698P 1998-06-19 1998-06-19
US8999398P 1998-06-19 1998-06-19
US9004298P 1998-06-19 1998-06-19
US8984498P 1998-06-19 1998-06-19
US9007798P 1998-06-19 1998-06-19
US9004598P 1998-06-19 1998-06-19
US9004898P 1998-06-19 1998-06-19
US8983398P 1998-06-19 1998-06-19
US9007898P 1998-06-19 1998-06-19
US9004198P 1998-06-19 1998-06-19
US9004398P 1998-06-19 1998-06-19
US8999498P 1998-06-19 1998-06-19
US60089844 1998-06-19
US60089853 1998-06-19
US60090043 1998-06-19
US60089833 1998-06-19
US60090040 1998-06-19
US60090078 1998-06-19
US60089999 1998-06-19
US60090039 1998-06-19
US60090047 1998-06-19
US60089991 1998-06-19
US60090077 1998-06-19
US60089997 1998-06-19
US60090048 1998-06-19
US60090072 1998-06-19
US60090042 1998-06-19
US60090000 1998-06-19
US60090041 1998-06-19
US60090035 1998-06-19
US60089993 1998-06-19
US60090036 1998-06-19
US60090079 1998-06-19
US60089878 1998-06-19
US60089994 1998-06-19
US60089992 1998-06-19
US60090044 1998-06-19
US60090076 1998-06-19
US60090045 1998-06-19
US60090080 1998-06-19
US11171598P 1998-12-08 1998-12-08
US60111715 1998-12-08
PCT/US1999/013820 WO1999066303A2 (en) 1998-06-19 1999-06-17 Identification and use of differentially expressed genes and polynucleotide sequences

Publications (1)

Publication Number Publication Date
AU4825699A true AU4825699A (en) 2000-01-05

Family

ID=27586849

Family Applications (2)

Application Number Title Priority Date Filing Date
AU48256/99A Abandoned AU4825699A (en) 1998-06-19 1999-06-17 Identification and use of differentially expressed genes and polynucleotide sequences
AU52044/99A Abandoned AU5204499A (en) 1998-06-19 1999-06-18 Preparation and use of superior vaccines

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU52044/99A Abandoned AU5204499A (en) 1998-06-19 1999-06-18 Preparation and use of superior vaccines

Country Status (5)

Country Link
EP (1) EP1086215A4 (en)
JP (1) JP2002534056A (en)
AU (2) AU4825699A (en)
CA (1) CA2335452A1 (en)
WO (1) WO1999065924A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6825333B1 (en) 1999-08-20 2004-11-30 Chiron Corporation EGFH2 genes and gene products
US7041445B2 (en) * 1999-11-15 2006-05-09 Clontech Laboratories, Inc. Long oligonucleotide arrays
WO2001073031A2 (en) * 2000-03-28 2001-10-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
US6632630B2 (en) 2000-03-29 2003-10-14 Aclara Biosciences, Inc. Monooxygenase assays
EP1497424A1 (en) 2002-04-22 2005-01-19 Bioniche Life Sciences Inc. Oligonucleotide compositions and their use for the modulation of immune responses
AU2003237367A1 (en) 2002-06-03 2003-12-19 Chiron Corporation Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer
WO2008047128A2 (en) * 2006-10-18 2008-04-24 Nazneen Rahman Materials and methods for determining susceptibility to cancer
US9150927B2 (en) * 2009-10-12 2015-10-06 Medimmune, Llc Quantification of IR-A and IR-B for tumor classification
EP2322656A1 (en) * 2009-11-17 2011-05-18 Centre National de la Recherche Scientifique (C.N.R.S) Methods for diagnosing skin diseases

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3940598A1 (en) * 1989-12-08 1991-06-13 Behringwerke Ag TOXOPLASMA GONDII-ANTIGENE, THEIR PRODUCTION AND USE
JPH03503524A (en) * 1985-10-30 1991-08-08 バイオジェン インコーポレイテッド Cleavage dimer of Mullerian canal inhibitor-like polypeptide
WO1989008114A1 (en) * 1988-02-25 1989-09-08 The General Hospital Corporation Rapid immunoselection cloning method
AU3348189A (en) * 1988-03-04 1989-09-22 La Jolla Cancer Research Foundation Germ cell alkaline phosphatase gene and protein produced thereby
DE68925769T2 (en) * 1988-06-29 1996-08-08 Ml Technology Ventures Recombinant hyopneumoniae antigen and its use
ATE123810T1 (en) * 1988-08-23 1995-06-15 Dana Farber Cancer Inst Inc ALPHA SUBUNITY OF THE LFA-1 LEUKOCYTE ADHESION RECEPTOR.
US5191064A (en) * 1988-09-30 1993-03-02 The Research Foundation For Microbial Diseases (Osaka University) Non-a, non-b hepatitis virus antigen peptide
WO1990008160A1 (en) * 1989-01-20 1990-07-26 Imperial Cancer Research Technology Ltd. Growth factor receptor-like peptides without tyrosine-kinase activity
WO1991008217A1 (en) * 1989-12-05 1991-06-13 The Regents Of The University Of California Human intestinal mucins
CA2086334A1 (en) * 1990-06-29 1991-12-30 The Regents Of The University Of Michigan Neurofibromatosis gene
US5866330A (en) * 1995-09-12 1999-02-02 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression

Also Published As

Publication number Publication date
CA2335452A1 (en) 1999-12-23
WO1999065924A2 (en) 1999-12-23
AU5204499A (en) 2000-01-05
EP1086215A4 (en) 2005-10-19
EP1086215A2 (en) 2001-03-28
JP2002534056A (en) 2002-10-15
WO1999065924A3 (en) 2000-04-13

Similar Documents

Publication Publication Date Title
AU6037199A (en) Rac-like genes from maize and methods of use
EP1233780A4 (en) Identification of sortase gene
AU3228597A (en) Identification of differentially methylated and mutated nucleic acids
IL131486A0 (en) Gene sequencer and methods
AU3560399A (en) Tumor associated nucleic acids and uses therefor
AU1389597A (en) Novel dna glycosylases and their use
AU2686200A (en) Novel nucleic acid and amino acid sequences
EP1060269A4 (en) Production and use of normalized dna libraries
AU4174397A (en) Methods for identification and isolation of specific nucleotide sequences in cdna and genomic dna
EP1144682A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
IL136349A0 (en) Virulence-associated nucleic acid sequences and uses thereof
AU4825699A (en) Identification and use of differentially expressed genes and polynucleotide sequences
AU3911897A (en) Phospholipase d and dna sequences
AU3979395A (en) DNA sequences and their use
AU6833996A (en) Identification of bases in nucleic acid sequences
AU4318199A (en) Nucleotide and protein sequences of gpr1 and methods based thereon
AU4894696A (en) Detection of nucleic acid sequences
AU4860299A (en) (zap-3) tumor associated genes and their uses
AU6550598A (en) Antithrombin protein and dna sequences
AU3975799A (en) (rhoh) genes and their uses
GB9719359D0 (en) The Use of DNA Sequences
AU8823898A (en) Identification of sortase gene
AU1928801A (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
AUPP549898A0 (en) Genetic sequences and uses therefor
AU6387699A (en) Rac-like genes and methods of use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase